中国患者结膜黑色素瘤:局部复发、转移、死亡率及与白人患者的比较
这项队列研究纳入1996至2016年间57例病理确诊结膜黑色素瘤的连续患者(57眼),评估局部复发、转移和肿瘤相关死亡及其预测因素,并比较中国与白人患者的临床特征和结局。中国患者表现出更侵袭性的临床体征和更差的预后,肿瘤出血是肿瘤相关死亡和转移的独立危险因素。
要点
- 57例中国结膜黑色素瘤患者中,29例(51%)发生局部复发,20例(35%)发生转移,14例(25%)死于结膜黑色素瘤。
- 肿瘤出血是肿瘤相关死亡的独立危险因素(HR 18.81,P=0.01),也是转移的独立危险因素(HR 4.57,P=0.02)。
- 与美国、德国和英国白人患者相比,中国患者男性更多(P<0.01)、更年轻(P=0.03),且更具侵袭性临床特征和更差预后。
核心结论
- 结膜黑色素瘤在中国人群中是一种罕见的恶性肿瘤,具有很高的致死潜力;应特别关注有肿瘤出血的患者。
- 与白人患者相比,中国患者表现出更具侵袭性的临床体征和更差的预后。
研究设计与样本
- 本队列研究纳入1996年至2016年间57例病理确诊结膜黑色素瘤的连续患者的57只眼,复习病历以分析与局部复发、转移和肿瘤相关死亡相关的因素,并对所有符合条件患者随访这三种结局指标。
- 比较中国与白人患者的人口学数据、临床特征和结局。
主要发现
- 平均随访时间为52.2 ± 49.4个月;57例患者中29例(51%)发生局部复发,1年、5年和10年复发率分别为31.0%、59.7%和66.4%。
- 随访中发现的治疗并发症包括干眼(32例,56.1%)、睑缘不规则(25例,43.9%)、眼睑退缩(18例,31.6%)、上睑下垂(9例,15.8%)、黏膜移植重建的睑板混合色素沉着、角膜混浊(6例,10.5%)和睑球粘连(2例,3.5%)。
- 20例(35%)患者发生转移,1年、5年和10年转移率分别为16.7%、38.7%和50.9%;14例(25%)患者死于结膜黑色素瘤,中位生存时间为24个月,1年、5年和10年肿瘤相关死亡率分别为3.8%、30.5%和37.4%。
- 肿瘤出血是肿瘤相关死亡的独立危险因素(风险比[HR] 18.81,P=0.01),也是转移的独立危险因素(HR 4.57,P=0.02)。
- 与来自美国、德国和英国的白人患者相比,中国患者男性更多(P<0.01)且更年轻(P=0.03);初诊时更多中国患者为原发肿瘤起源(P<0.01)、上皮样细胞型(P<0.01)、非眼球表面肿瘤位置(P<0.01)、基底直径更大(P=0.04)、多灶性肿瘤(P<0.01)、有滋养血管(P<0.01)、眼睑(P<0.01)和眼眶受累(P<0.01)以及更晚的T分期(P<0.01)。
关键数值与推荐
- 肿瘤出血是肿瘤相关死亡的独立危险因素(HR 18.81,P=0.01),也是转移的独立危险因素(HR 4.57,P=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the prognosis in Chinese patients with conjunctival melanoma and determine its predictors. Further, to explore the racial differences in clinical characteristics and outcomes between Chinese and Caucasian patients. METHODS: This cohort study included 57 eyes of 57 consecutive patients with pathologically verified conjunctival melanoma between 1996 and 2016. Medical records were reviewed for factors associated with the local recurrence, metastasis, and tumor-related mortality. All eligible patients were followed up for these three outcome measures. The demographic data, clinical characteristics, and outcomes were compared between Chinese and Caucasian patients. RESULTS: The mean follow-up period was 52.2 ± 49.4 months. Among the total 57 patients, 29 (51%) patients experienced local recurrence. The 1-, 5-, and 10-year recurrence rate was 31.0%, 59.7%, and 66.4%, respectively. Treatment complications detected in the follow-up included dry eye (32, 56.1%), irregular eyelid margin (25, 43.9%), eyelid retraction (18, 31.6%), blepharoptosis (9, 15.8%), mixed pigmentation of the tarsus reconstructed by mucosal membrane graft, corneal opacities (6, 10.5%), and symblepharon (2, 3.5%). Twenty (35%) patients developed metastasis. The 1-, 5-, and 10-year metastasis rate was 16.7%, 38.7%, and 50.9%, respectively. Fourteen (25%) patients died of conjunctival melanoma, with a median survival time of 24 months. The 1-, 5-, and 10-year tumor-related mortality was 3.8%, 30.5%, and 37.4%, respectively. Tumor hemorrhage is an independent risk factor for tumor-related death (hazard ratio [HR]: 18.81, P = 0.01) and metastasis (HR: 4.57, P = 0.02). Significant differences were noted between Chinese and Caucasians patients from America, Germany, and England in demographics, clinical characteristics, and outcomes. Compared to Caucasians, Chinese patients tended to have more male cases (P < 0.01) and to be younger (P = 0.03). At initial presentation, more Chinese patients had de novo tumor origin (P < 0.01), epithelioid cell type (P < 0.01), nonbulbar tumor location (P < 0.01), greater basal diameter (P = 0.04), multifocal tumor (P < 0.01), feeder vessels (P < 0.01), eyelid (P < 0.01) and orbit involvement (P < 0.01), and advanced T stages (P < 0.01). Over a similar follow-up period with Caucasians patients (52.2 vs. 52 months, P = 0.97), a significantly larger proportion of Chinese patients exhibited eyelid invasion (P = 0.04) and orbital invasion (P < 0.01) at follow-up, local recurrence (P < 0.01), metastasis (P < 0.01), and tumor-related death (P < 0.01). CONCLUSIONS: Conjunctival melanoma is a rare malignancy with great potential for mortality in Chinese. Special attention should be paid to patients with tumor hemorrhage. Compared to Caucasians, Chinese patients exhibit more aggressive clinical signs with compromised prognosis.
引用
- Zhou C, Wang Y, Jia R, et al. Conjunctival Melanoma in Chinese Patients: Local Recurrence, Metastasis, Mortality, and Comparisons With Caucasian Patients. Invest Ophthalmol Vis Sci. 2017. PMID: 29059312. doi:10.1167/iovs.17-22376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。